BridgeMD
New treatment option for Ischemic Stroke
Official title Gait Recovery in Patients After Acute Ischemic Stroke
ClinicalTrials.gov ID: NCT04824482
What this study is testing
- What it's testing
- More than 80% of ischemic stroke (IS) patients have some walking disability, which restricts their independence in the activities of daily living. Physical therapy (PT) significantly contributes to gait recovery in patients after IS.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Ischemic stroke detected on magnetic resonance imaging (MRI) with NIHSS score 1-12 points at the time of enrolment
- Lower limb movement impairment with a score of at least 1 point on the NIH Stroke Scale (NIHSS) at the time of enrolment
- Dependency in walking according to Functional Ambulatory Category (FAC) with score interval \ (supervision or assistance, or both, must be given in...
You likely can't join if
- Previous history of any stroke, either ischemic or hemorrhagic
- Other diseases modifying or limiting walking ability, currently receiving rehabilitation or participation in another study
- Significant/symptomatic ischemic heart disease or significant/symptomatic peripheral arterial disease
- Obesity (BMI ≥ 40), or weight higher than 110 kg (weight limit for the robot-assisted gait training)
- Sensory aphasia with the inability to understand having been verified by a certified speech therapist.
- Moderate or severe depression present at the time of enrolment assessed using the Beck scale, with a score above 10.
See the full eligibility criteria
- Ischemic stroke detected on magnetic resonance imaging (MRI) with NIHSS score 1-12 points at the time of enrolment
- Lower limb movement impairment with a score of at least 1 point on the NIH Stroke Scale (NIHSS) at the time of enrolment
- Dependency in walking according to Functional Ambulatory Category (FAC) with score interval \ (supervision or assistance, or both, must be given in performing walking)
- Previous history of any stroke, either ischemic or hemorrhagic
- Other diseases modifying or limiting walking ability, currently receiving rehabilitation or participation in another study
- Significant/symptomatic ischemic heart disease or significant/symptomatic peripheral arterial disease
- Obesity (BMI ≥ 40), or weight higher than 110 kg (weight limit for the robot-assisted gait training)
- Sensory aphasia with the inability to understand having been verified by a certified speech therapist.
- Moderate or severe depression present at the time of enrolment assessed using the Beck scale, with a score above 10.
- Known cognitive impairment
- Previous disability or dependence in the daily activities assessed using the modified Rankin Scale with a score of 3 and more points
- Currently receiving dialysis
- Diagnosed and/or receiving treatment for cancer
- Presence of other orthopedic or neurological conditions affecting the lower extremities
- For fMRI: Pregnancy; electronic implants, including cochlear implant, pacemaker, neurostimulator; incompatible metallic implants, including aneurysm clip; metallic intraocular foreign body; large tattoos; unremovable...
The study team makes the final eligibility decision.
Where it's taking place
- Olomouc, Czechia
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Olomouc, Czechia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.